Related Experiment Video
Updated: Jul 24, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment
Xuemeng Xu1,2, Qiu Peng1, Xianjie Jiang1
1Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.
Abstract:
Metabolic reprogramming and epigenetic modifications are hallmarks of cancer cells. In cancer cells, metabolic pathway activity varies during tumorigenesis and cancer progression, indicating regulated metabolic plasticity. Metabolic changes are often closely related to epigenetic changes, such as alterations in the expression or activity of epigenetically modified enzymes, which may exert a direct or an indirect influence on cellular metabolism. Therefore, exploring the mechanisms underlying epigenetic modifications regulating the reprogramming of tumor cell metabolism is important for further understanding tumor pathogenesis. Here, we mainly focus on the latest studies on epigenetic modifications related to cancer cell metabolism regulations, including changes in glucose, lipid and amino acid metabolism in the cancer context, and then emphasize the mechanisms related to tumor cell epigenetic modifications. Specifically, we discuss the role played by DNA methylation, chromatin remodeling, noncoding RNAs and histone lactylation in tumor growth and progression. Finally, we summarize the prospects of potential cancer therapeutic strategies based on metabolic reprogramming and epigenetic changes in tumor cells.
Insights
Cancer cells exhibit metabolic plasticity, reprogramming their metabolism through epigenetic changes. Understanding these epigenetic modifications, including DNA methylation and histone lactylation, is key to developing new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer cells undergo metabolic reprogramming and epigenetic modifications.
- Metabolic pathway activity in tumors is plastic and changes during progression.
- Metabolic and epigenetic changes are interconnected, influencing tumor pathogenesis.
Purpose of the Study:
- To review recent studies on epigenetic modifications regulating cancer cell metabolism.
- To explore mechanisms of epigenetic regulation in glucose, lipid, and amino acid metabolism.
- To highlight the role of epigenetic factors in tumor growth and therapeutic strategies.
Main Methods:
- Literature review of recent studies on cancer metabolism and epigenetics.
- Focus on mechanisms of DNA methylation, chromatin remodeling, noncoding RNAs, and histone lactylation.
- Analysis of the interplay between epigenetic changes and metabolic reprogramming in cancer.
Main Results:
- Epigenetic modifications significantly influence cancer cell metabolism.
- DNA methylation, chromatin remodeling, noncoding RNAs, and histone lactylation are key epigenetic regulators.
- These epigenetic changes impact glucose, lipid, and amino acid metabolism in tumors.
Conclusions:
- Epigenetic modifications are crucial for metabolic reprogramming in cancer cells.
- Targeting epigenetic mechanisms offers potential for novel cancer therapeutics.
- Further research into these mechanisms can advance our understanding of tumor pathogenesis.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Methods of Nuclear Reprogramming
Somatic to iPS Cell Reprogramming
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Introduction to Nuclear Reprogramming

